Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0167 | 0.4265 | 0.414 |
Brugia malayi | nuclear receptor NHR-88 | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0939 | 0.0939 |
Mycobacterium tuberculosis | 6-phosphofructokinase PfkB (phosphohexokinase) (phosphofructokinase) | 0.0043 | 0.0939 | 1 |
Onchocerca volvulus | 0.0043 | 0.0939 | 0.1006 | |
Brugia malayi | Steroid receptor seven-up type 2 | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | adenosine kinase | 0.0379 | 1 | 1 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0043 | 0.0939 | 0.0741 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.4497 | 0.4497 |
Trypanosoma brucei | ribokinase, putative | 0.0043 | 0.0939 | 0.0741 |
Leishmania major | putative PfkB family sugar kinase | 0.0043 | 0.0939 | 0.0741 |
Echinococcus multilocularis | geminin | 0.0175 | 0.4497 | 0.4497 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.001 | 0.0055 | 0.0055 |
Leishmania major | adenosine kinase-like protein | 0.0043 | 0.0939 | 0.0741 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0055 | 0.0055 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0776 | 0.0776 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.001 | 0.0055 | 0.0055 |
Trypanosoma brucei | protein kinase, putative | 0.0167 | 0.4265 | 0.414 |
Entamoeba histolytica | fructokinase, putative | 0.0043 | 0.0939 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0776 | 0.0776 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | steroid hormone receptor | 0.001 | 0.0055 | 0.0055 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0167 | 0.4265 | 0.414 |
Toxoplasma gondii | kinase, pfkB family protein | 0.0379 | 1 | 1 |
Echinococcus multilocularis | FTZ F1 alpha | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0255 | 0.6636 | 0.6636 |
Echinococcus granulosus | pseudouridine metabolizing bifunctional protein | 0.0043 | 0.0939 | 0.0939 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0055 | 0.0055 |
Entamoeba histolytica | tagatose-6-phosphate kinase, putative | 0.0043 | 0.0939 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0379 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0175 | 0.4497 | 0.4497 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0167 | 0.4265 | 0.414 |
Brugia malayi | isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Mycobacterium leprae | Probable adenosine kinase adk | 0.0043 | 0.0939 | 0.5 |
Brugia malayi | Isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Schistosoma mansoni | coup transcription factor | 0.001 | 0.0055 | 0.0055 |
Trypanosoma brucei | ribokinase, putative | 0.0043 | 0.0939 | 0.0741 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | MAP kinase sur-1 | 0.0167 | 0.4265 | 0.4265 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | thyroid hormone receptor | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | adenosine kinase | 0.0379 | 1 | 1 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | nuclear hormone receptor | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Leishmania major | adenosine kinase, putative | 0.0379 | 1 | 1 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | pseudouridine metabolizing bifunctional protein | 0.0043 | 0.0939 | 0.0939 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0379 | 1 | 1 |
Entamoeba histolytica | ribokinase, putative | 0.0043 | 0.0939 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0016 | 0.0214 | 0.0214 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.001 | 0.0055 | 0.0055 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0167 | 0.4265 | 0.4265 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | nuclear hormone receptor | 0.001 | 0.0055 | 0.0055 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0167 | 0.4265 | 0.4265 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0939 | 0.0939 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0055 | 0.0055 |
Onchocerca volvulus | 0.0336 | 0.8835 | 1 | |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0123 | 0.3102 | 0.3102 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0167 | 0.4265 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0167 | 0.4265 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.001 | 0.0055 | 0.0055 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0167 | 0.4265 | 0.414 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.001 | 0.0055 | 0.0055 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0379 | 1 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.001 | 0.0055 | 0.0055 |
Leishmania major | tagatose-6-phosphate kinase-like protein | 0.0043 | 0.0939 | 0.0741 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0939 | 0.0939 |
Schistosoma mansoni | ribokinase | 0.0043 | 0.0939 | 0.0939 |
Brugia malayi | Ribokinase | 0.0043 | 0.0939 | 0.0939 |
Onchocerca volvulus | Putative pyridoxal kinase | 0.0043 | 0.0939 | 0.1006 |
Schistosoma mansoni | adenosine kinase | 0.0379 | 1 | 1 |
Leishmania major | adenosine kinase-like protein | 0.0043 | 0.0939 | 0.0741 |
Leishmania major | tagatose-6-phosphate kinase-like protein | 0.0043 | 0.0939 | 0.0741 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.001 | 0.0055 | 0.0055 |
Trypanosoma brucei | adenosine kinase, putative | 0.0379 | 1 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0167 | 0.4265 | 0.4265 |
Trypanosoma cruzi | ribokinase, putative | 0.0043 | 0.0939 | 0.0741 |
Leishmania major | ribokinase, putative | 0.0043 | 0.0939 | 0.0741 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0167 | 0.4265 | 0.4265 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0167 | 0.4265 | 0.4265 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0055 | 0.0055 |
Mycobacterium ulcerans | carbohydrate kinase CbhK | 0.0043 | 0.0939 | 0.5 |
Loa Loa (eye worm) | steroid hormone receptor | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0255 | 0.6636 | 0.6636 |
Onchocerca volvulus | Ribokinase homolog | 0.0043 | 0.0939 | 0.1006 |
Brugia malayi | MH2 domain containing protein | 0.0123 | 0.3102 | 0.3102 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.001 | 0.0055 | 0.0055 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0016 | 0.0214 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.001 | 0.0055 | 0.0055 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0016 | 0.0214 | 0.5 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.001 | 0.0055 | 0.0055 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0167 | 0.4265 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0776 | 0.0776 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0043 | 0.0939 | 0.0741 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | ecdysteroid receptor | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0167 | 0.4265 | 0.4265 |
Mycobacterium ulcerans | fructokinase, PfkB | 0.0043 | 0.0939 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.001 | 0.0055 | 0.0055 |
Entamoeba histolytica | kinase, PfkB family | 0.0043 | 0.0939 | 1 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.001 | 0.0055 | 0.0055 |
Mycobacterium tuberculosis | Adenosine kinase | 0.0043 | 0.0939 | 1 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.001 | 0.0055 | 0.0055 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0167 | 0.4265 | 0.414 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0055 | 0.0055 |
Echinococcus granulosus | ribokinase | 0.0043 | 0.0939 | 0.0939 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Echinococcus granulosus | adenosine kinase | 0.0379 | 1 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.001 | 0.0055 | 0.0055 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0167 | 0.4265 | 0.414 |
Echinococcus granulosus | FTZ F1 alpha | 0.001 | 0.0055 | 0.0055 |
Toxoplasma gondii | kinase, pfkB family protein | 0.0043 | 0.0939 | 0.0741 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0167 | 0.4265 | 0.414 |
Mycobacterium tuberculosis | Ribokinase RbsK | 0.0043 | 0.0939 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0123 | 0.3102 | 0.3102 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0214 | 0.0214 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.001 | 0.0055 | 0.0055 |
Trypanosoma brucei | adenosine kinase, putative | 0.0379 | 1 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0167 | 0.4265 | 1 |
Entamoeba histolytica | Hypothetical protein T24C12.3, putative | 0.0043 | 0.0939 | 1 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0055 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0055 | 0.0055 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0167 | 0.4265 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0776 | 0.0776 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.001 | 0.0055 | 0.0055 |
Echinococcus multilocularis | ribokinase | 0.0043 | 0.0939 | 0.0939 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0776 | 0.0776 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.001 | 0.0055 | 0.0055 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.4497 | 0.4497 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0167 | 0.4265 | 0.414 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.001 | 0.0055 | 0.0055 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
BWC (functional) | = -3.95 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.069 nmol/kg dose against sc inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -3.95 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.069 nmol/kg dose against sc inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -3.9 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.17 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -3.9 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.17 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -3.5 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.11 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -3.5 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.11 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2.6 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.069 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2.6 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.069 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2.55 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.052 nmol/kg dose against sc inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2.55 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.052 nmol/kg dose against sc inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2.35 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.035 nmol/kg dose against sc inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2.35 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.035 nmol/kg dose against sc inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.052 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -2 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.052 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -1.6 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.035 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
BWC (functional) | = -1.6 g | Antitumor activity measured as Body weight change (BWC) between day 1 and 5 at 0.035 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (ADMET) | 0 day | Antitumor a dose 0.23 nmol/kg against po inoculated P388 leukemia in CDF1 mice; Toxic | ChEMBL. | 6876088 |
MST (functional) | = 17 day | Antitumor a dose 0.035 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 17 day | Antitumor a dose 0.035 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 20.5 day | Antitumor a dose 0.035 nmol/Kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 20.5 day | Antitumor a dose 0.035 nmol/Kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 21.5 day | Antitumor a dose 0.052 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 21.5 day | Antitumor a dose 0.052 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 22 day | Antitumor a dose 0.052 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 22 day | Antitumor a dose 0.052 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 23.5 day | Antitumor a dose 0.069 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 23.5 day | Antitumor a dose 0.069 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 24.5 day | Antitumor a dose 0.11 nmol/kg against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 24.5 day | Antitumor a dose 0.11 nmol/kg against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 26.5 day | Antitumor a dose 0.069 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 26.5 day | Antitumor a dose 0.069 nmol/kg against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 34 day | Antitumor a dose 0.17 nmol/kg against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
MST (functional) | = 34 day | Antitumor a dose 0.17 nmol/kg against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | 0 % | Antitumor activity measured as T/C at 0.23 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice; Toxic | ChEMBL. | 6876088 |
T/C (functional) | = 141 % | Antitumor activity measured as T/C at 0.035 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 141 % | Antitumor activity measured as T/C at 0.035 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 148 % | Antitumor activity measured as T/C at 0.052 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 148 % | Antitumor activity measured as T/C at 0.052 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 162 % | Antitumor activity measured as T/C at 0.069 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 162 % | Antitumor activity measured as T/C at 0.069 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 168 % | Antitumor activity measured as T/C at 0.11 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 168 % | Antitumor activity measured as T/C at 0.11 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 170 % | Antitumor activity measured as T/C at 0.035 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 170 % | Antitumor activity measured as T/C at 0.035 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 220 % | Antitumor activity measured as T/C at 0.052 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 220 % | Antitumor activity measured as T/C at 0.052 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 234 % | Antitumor activity measured as T/C at 0.17 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 234 % | Antitumor activity measured as T/C at 0.17 nmol/kg dose against po inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 265 % | Antitumor activity measured as T/C at 0.069 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
T/C (functional) | = 265 % | Antitumor activity measured as T/C at 0.069 nmol/kg dose against ip inoculated P388 leukemia in CDF1 mice | ChEMBL. | 6876088 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.